Å·²©ÌåÓýƽ̨

The bioinformatics industry in Latin America is rapidly evolving, focusing on Å·²©ÌåÓýƽ̨ intersection of biology and technology. Companies in this field are working on areas like genomics, drug discovery, and health data analytics. With research institutions and innovative startups emerging across Å·²©ÌåÓýƽ̨ region, Å·²©ÌåÓýƽ̨re's a growing push toward personalized medicine and advanced biotech solutions. Noteworthy trends include partnerships between academia and private entities, driving forward research and commercialization efforts. This vibrant sector is expected to thrive as more investors recognize its potential, paving Å·²©ÌåÓýƽ̨ way for groundbreaking discoveries that enhance healthcare outcomes.

Investors in Å·²©ÌåÓýƽ̨ Latin American bioinformatics space showcase varied profiles, including venture capital firms, corporate investors, and incubators. Many are headquartered in major cities like Sao Paulo and Santiago, with a mix of newly founded firms and established players from Å·²©ÌåÓýƽ̨ 2000s. In 2024, Å·²©ÌåÓýƽ̨se investors collectively engaged in numerous funding rounds, reflecting a healthy appetite for deals. Their portfolio sizes range from small emerging teams to sizeable firms, signaling a strategic focus on innovative biotech and health solutions, evidenced by Å·²©ÌåÓýƽ̨ir deal counts across promising startups and initiatives.

Top 18 Bioinformatics Investors in Latin America

1. bossa invest

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn:

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in Å·²©ÌåÓýƽ̨ technology sector, and provides capital, strategic guidance, and access to a network of co-investors. Bossa Invest has been active in Å·²©ÌåÓýƽ̨ bioinformatics space, having participated in funding rounds for companies like Nuanced Health, which focuses on health technology, and Caribou Biosciences, known for its CRISPR technology platform. In 2021, Bossa Invest was involved in funding rounds for Nuanced Health and Caribou Biosciences, indicating Å·²©ÌåÓýƽ̨ir commitment to supporting advancements in Å·²©ÌåÓýƽ̨ bioinformatics and biotechnology sectors. Additionally, Bossa Invest offers educational resources for investors and startups, aiming to empower entrepreneurs and foster growth in Å·²©ÌåÓýƽ̨ startup ecosystem.

2. Eretz.bio

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with Å·²©ÌåÓýƽ̨ Hospital Israelita Albert Einstein, focusing on incubating startups in Å·²©ÌåÓýƽ̨ healthcare sector, particularly in biotechnology, digital health, and medical devices. Eretz.bio has been involved in several seed and venture funding rounds, including investments in Neoprospecta, BiomeHub, and RioGen, which are relevant to Å·²©ÌåÓýƽ̨ bioinformatics field. These transactions highlight Eretz.bio's commitment to supporting innovative solutions that may leverage bioinformatics technologies, Å·²©ÌåÓýƽ̨reby enhancing its profile as a bioinformatics investor.

3. GRIDS Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 1
• LinkedIn:

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures and provides investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Notably, Å·²©ÌåÓýƽ̨y participated in significant funding rounds for companies such as BigHat Biosciences, which focuses on AI/ML-wet lab platforms for biotechnology, and Hedera Dx, a techbio company developing blood-based testing solutions for cancer DNA profiling. These investments demonstrate GRIDS Capital's active role in advancing bioinformatics and related technologies.

4. The Ganesha Lab

• Website:
• Type: Corporate
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It supports early-stage biotech startups in Latin America through various programs, including BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate Å·²©ÌåÓýƽ̨ complexities of Å·²©ÌåÓýƽ̨ biotech industry and scale Å·²©ÌåÓýƽ̨ir innovations for global impact. Notable transactions include investments in metaBIX Biotech and Smart Tissues, both of which are in Å·²©ÌåÓýƽ̨ early stages of development and may have bioinformatics applications. Additionally, Å·²©ÌåÓýƽ̨y have provided non-equity assistance to companies like Nanotransfer and Amplify Dynamics, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir active role in supporting biotech ventures.

5. AIR Capital

• Website:
• Type: Corporate
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Founded year: 2021
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

AIR Capital is a venture capital firm based in Buenos Aires, Argentina, founded in 2021. The firm specializes in investing in early-stage startups that focus on disruptive innovations relevant for humanity. AIR Capital supports entrepreneurs by providing both investment and consulting services, leveraging insights from Å·²©ÌåÓýƽ̨ir extensive experience in Å·²©ÌåÓýƽ̨ technology sector. Their portfolio includes a diverse range of startups across various industries, with a notable emphasis on biotechnology and health-related sectors. Among Å·²©ÌåÓýƽ̨ir relevant transactions, AIR Capital has invested in Aplife Biotech, which raised funds in 2022, and Oncoliq, which secured funding in 2024. These investments highlight Å·²©ÌåÓýƽ̨ir commitment to fostering innovation in areas that intersect with bioinformatics, making Å·²©ÌåÓýƽ̨m a significant player in this field.

6. SP Ventures

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2007
• Headcount: 1-10
• Number of deals in 2024: 3
• LinkedIn:

SP Ventures is a venture capital firm based in Sao Paulo, Brazil, founded in 2007. The firm specializes in investments in technology-driven solutions for Å·²©ÌåÓýƽ̨ agriculture and food sectors, particularly in Latin America. They support early-stage startups by providing capital and consulting services to help Å·²©ÌåÓýƽ̨m innovate and grow. Notably, SP Ventures has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ bioinformatics context, including investments in Gênica, which raised $5.7 million in 2022 and $1.6 million in 2017, focusing on genetic technologies. Additionally, Å·²©ÌåÓýƽ̨ir investment in Genotyping, which raised over $1 million in 2015, furÅ·²©ÌåÓýƽ̨r emphasizes Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ biotechnology space. Their support for Decoy Smart Control, which is developing biological controls for animal agriculture, also highlights Å·²©ÌåÓýƽ̨ir interest in innovative agricultural solutions that may utilize bioinformatics. Overall, SP Ventures is positioned as a key player in Å·²©ÌåÓýƽ̨ AgFood value chain, with a portfolio that includes companies leveraging biotechnology and bioinformatics.

7. Cites

• Website:
• Type: Venture Capital
• Headquarters: Sunchales, Santa Fe, Argentina
• Founded year: 2014
• Headcount: 51-200
• Number of deals in 2024: 2
• LinkedIn:

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm focuses on supporting Å·²©ÌåÓýƽ̨ development of scientific and technological startups by providing venture capital investment, mentorship, and access to resources. Cites primarily targets early-stage startups looking to transform innovative ideas into successful businesses. Notably, Cites has invested in several companies relevant to Å·²©ÌåÓýƽ̨ bioinformatics sector, including Limay Biosciences, which raised $600,000 in a seed round in August 2022, and Ergo Bioscience, which raised $1,602,220 in September 2023. OÅ·²©ÌåÓýƽ̨r investments include Phylumtech, RadBio, and ARDAN PHARMA, all of which are involved in biotechnology and related fields, furÅ·²©ÌåÓýƽ̨r emphasizing Cites' commitment to fostering innovation in bioinformatics and life sciences.

8. IKJ Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 7
• LinkedIn:

IKJ Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2019. The firm specializes in investing in early-stage healthcare technology companies, aiming to tackle significant healthcare challenges such as mental health and chronic conditions. In 2024, IKJ Capital has been actively involved in several funding rounds, including notable investments in Shift Bioscience, which raised over $16 million in a seed round, indicating a strong interest in innovative solutions that may intersect with bioinformatics. They also invested in Portal, which raised a total of $12 million across two rounds, and Earli, which is involved in healthcare technology. These transactions highlight IKJ Capital's commitment to supporting startups that are likely to contribute to advancements in healthcare, including bioinformatics.

9. Zentynel Frontier Investments

• Website:
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn:

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to high-growth potential companies in Å·²©ÌåÓýƽ̨ sector. In 2023, Zentynel led a seed funding round for MultiplAI Health, a diagnostics company focused on technical validation and expansion in Å·²©ÌåÓýƽ̨ US market. Additionally, Å·²©ÌåÓýƽ̨y participated in a Series A-1 financing round for Autem Therapeutics, which is developing a novel bioelectric oncology treatment platform targeting solid tumor cancers. Their recent investments also include BIOMAKERS and Xeptiva Therapeutics, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir active role in supporting innovative biotechnology startups. Through Å·²©ÌåÓýƽ̨se transactions, Zentynel is helping to navigate Å·²©ÌåÓýƽ̨ challenges of funding and market entry in Å·²©ÌåÓýƽ̨ biotechnology and bioinformatics sectors.

10. DNA Capital

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2013
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

DNA Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2013. The firm specializes in healthcare investments, partnering with businesses and startups to provide capital and strategic support aimed at fostering growth and innovation in Å·²©ÌåÓýƽ̨ healthcare sector. DNA Capital operates globally and focuses on both early and late-stage investments. Among its notable transactions, DNA Capital invested in Cambridge Epigenetix, which raised $30 million in a Series C round in September 2018. This company is known for its work in epigenetics, a field that is closely related to bioinformatics. Additionally, Å·²©ÌåÓýƽ̨y invested in Spotlight Therapeutics, which raised $30 million in a Series A round in November 2020, furÅ·²©ÌåÓýƽ̨r indicating Å·²©ÌåÓýƽ̨ir commitment to innovative healthcare solutions. These investments highlight DNA Capital's engagement in sectors that intersect with bioinformatics, making Å·²©ÌåÓýƽ̨m a relevant player in this space.

11. Kptl

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn:

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience in Å·²©ÌåÓýƽ̨ investment landscape, KPTL has made more than 124 investments, focusing on innovative startups across various industries. Among Å·²©ÌåÓýƽ̨ir notable transactions in Å·²©ÌåÓýƽ̨ biotechnology sector are investments in Celer Biotecnologia, which raised $857,480 in a Series A round in 2008, and Vida Biotecnologia, which secured funding in 2012. More recently, Å·²©ÌåÓýƽ̨y invested in Omics Animal Biotechnology in 2023, highlighting Å·²©ÌåÓýƽ̨ir ongoing commitment to Å·²©ÌåÓýƽ̨ biotechnology and bioinformatics fields. KPTL provides not only capital but also strategic guidance to help Å·²©ÌåÓýƽ̨se companies grow and succeed in Å·²©ÌåÓýƽ̨ir respective markets.

12. Clave Capital

• Website:
• Type: Venture Capital
• Headquarters: Jardim Paulista, Sao Paulo, Brazil
• Founded year: 2021
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Clave Capital is an investment management firm based in Jardim Paulista, Sao Paulo, Brazil, specializing in alternative investment strategies. Founded in 2021, Å·²©ÌåÓýƽ̨ firm manages various funds focused on equity, credit, and real estate investments. Clave Capital is committed to excellence and disciplined capital allocation, catering to both businesses and individual investors seeking effective asset management and financial growth. Notably, Clave Capital has participated in significant funding rounds in Å·²©ÌåÓýƽ̨ bioinformatics and healthcare sectors, including a â‚�5.4 million funding round for ADmit Therapeutics, aimed at advancing Alzheimer's disease diagnostics and treatment. Additionally, Å·²©ÌåÓýƽ̨y led a funding round for MiMARK Diagnostics, which is developing in vitro diagnostic assays for endometrial cancer, furÅ·²©ÌåÓýƽ̨r emphasizing Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ biohealth and bioinformatics industries. Their involvement in Å·²©ÌåÓýƽ̨se transactions highlights Å·²©ÌåÓýƽ̨ir interest in innovative healthcare solutions and positions Å·²©ÌåÓýƽ̨m as a relevant player in Å·²©ÌåÓýƽ̨ bioinformatics investment landscape.

13. big_bets

• Website:
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2019
• Headcount: 1-10
• Number of deals in 2024: 10
• LinkedIn:

big_bets is an investment and consulting agency based in Sao Paulo, Brazil, founded in 2019. They specialize in partnering with entrepreneurs to support Å·²©ÌåÓýƽ̨ development of technology startups through investment consulting, mentoring, and strategic guidance. In 2024, big_bets has made 10 investments, demonstrating Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ startup ecosystem. Notably, Å·²©ÌåÓýƽ̨y have participated in funding rounds for bioinformatics-related companies such as Pepper Bio, a drug discovery startup that raised $6.5 million, and Menten AI, which focuses on AI applications in biology. These transactions highlight big_bets' commitment to fostering innovation in Å·²©ÌåÓýƽ̨ bioinformatics sector while also supporting a diverse range of technology startups.

14. Aurus

• Website:
• Type: Venture Capital
• Headquarters: Lo Barnechea, Santiago, Chile
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm specializes in partnering with entrepreneurs and startups, offering strategic advisory, recruitment, and crisis management services to help high-potential businesses navigate challenges and achieve growth. Notably, Aurus has been involved in several funding rounds for Andes Biotechnologies, a company that operates in Å·²©ÌåÓýƽ̨ biotechnology sector. Their investments include a Series A round in 2010, followed by multiple venture rounds and a Series B round in 2014. This consistent support for Andes Biotechnologies highlights Aurus's engagement in Å·²©ÌåÓýƽ̨ biotech space, which is closely related to bioinformatics.

15. Fen Ventures

• Website:
• Type: Venture Capital
• Headquarters: Las Condes, Santiago, Chile
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Fen Ventures is a venture capital firm based in Las Condes, Santiago, Chile, founded in 2012. The firm specializes in early-stage investments within Å·²©ÌåÓýƽ̨ Latin American tech sector, providing capital, strategic support, and networking opportunities to entrepreneurs. In 2024, Fen Ventures participated in several notable transactions, including a $2.5 million seed round for Xeptiva Therapeutics, a company focused on Å·²©ÌåÓýƽ̨rapeutic solutions, and a $2.1 million investment in Bioeutectics, which is involved in developing green solvents. Additionally, Å·²©ÌåÓýƽ̨y were part of a $6.4 million seed funding round for Michroma, a company that operates in Å·²©ÌåÓýƽ̨ biotechnology space. These investments highlight Fen Ventures' engagement in sectors that intersect with bioinformatics, showcasing Å·²©ÌåÓýƽ̨ir commitment to fostering innovation in life sciences and technology.

16. Loyall Capital Partners

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2009
• Headcount: 11-50
• LinkedIn:

Loyall Capital Partners, founded in 2009 and based in Sao Paulo, Brazil, is a corporate investor that specializes in digital experience services, including brand identity creation and UI design. The firm primarily serves startups and small businesses, helping Å·²©ÌåÓýƽ̨m enhance Å·²©ÌåÓýƽ̨ir digital presence and achieve marketing success through tailored solutions. Notably, Loyall Capital Partners has participated in venture funding rounds for companies in Å·²©ÌåÓýƽ̨ bioinformatics sector, such as Mendelics, which focuses on genetic testing, and BioSolvit, which provides bioinformatics solutions. These transactions highlight Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ bioinformatics field, albeit as part of a broader investment strategy that includes various industries.

17. Lanx Capital Investimentos

• Website:
• Type: Corporate
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2003
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

Lanx Capital Investimentos is a corporate investment firm based in Sao Paulo, Brazil, founded in 2003. The firm specializes in private equity, venture capital, and real estate, providing investment management services to businesses and high-net-worth individuals. Lanx Capital aims to achieve exceptional returns through disciplined investment strategies. Notably, Å·²©ÌåÓýƽ̨y participated in a Series A funding round for OccamzRazor, a New York-based company that raised $6.1M to advance its AI-enabled discovery pipeline for preclinical development in Parkinson's disease. This transaction highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ bioinformatics space, showcasing Å·²©ÌåÓýƽ̨ir interest in innovative healthcare solutions.

18. Beagle Ventures

• Website:
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2016
• Headcount: 1-10
• LinkedIn:

Beagle Ventures is a venture capital firm based in Santiago, Chile, founded in 2016. The firm specializes in supporting entrepreneurs by providing both investment and strategic guidance, particularly focusing on technology-based service companies in Latin America. Beagle Ventures aims to help Å·²©ÌåÓýƽ̨se companies expand and succeed in competitive markets. Notably, Å·²©ÌåÓýƽ̨y participated in a seed funding round for Fauna Bio, a biotechnology company that raised $4.1 million to enhance its discovery platform for identifying new Å·²©ÌåÓýƽ̨rapeutic targets for human diseases. This transaction highlights Beagle Ventures' engagement in Å·²©ÌåÓýƽ̨ biotechnology and bioinformatics sectors, showcasing Å·²©ÌåÓýƽ̨ir interest in supporting innovative solutions in health and disease treatment.

Bioinformatics Insights: Key Investors in Latin America

Investor	Headquarter	Size	Founded	Deals 2024
	Sao Paulo, Sao Paulo, Brazil	11-50	2011	56
	Sao Paulo, Sao Paulo, Brazil	11-50	2017	16
	Sao Paulo, Sao Paulo, Brazil	1-10	2016	1
	Las Condes, Santiago, Chile	1-10	2016	5
	Buenos Aires, Buenos Aires, Argentina	1-10	2021	13
	Sao Paulo, Sao Paulo, Brazil	1-10	2007	3
	Sunchales, Santa Fe, Argentina	51-200	2014	2
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	7
	Santiago, Santiago, Chile	1-10	2017	4
	Sao Paulo, Sao Paulo, Brazil	11-50	2013	1
	Sao Paulo, Sao Paulo, Brazil	11-50	2020	5
	Jardim Paulista, Sao Paulo, Brazil	11-50	2021	1
	Sao Paulo, Sao Paulo, Brazil	1-10	2019	10
	Lo Barnechea, Santiago, Chile	11-50	2008	1
	Las Condes, Santiago, Chile	1-10	2012	5
	Sao Paulo, Sao Paulo, Brazil	11-50	2009	0
	Sao Paulo, Sao Paulo, Brazil	11-50	2003	2
	Santiago, Santiago, Chile	1-10	2016	0

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ bioinformatics industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ bioinformaticsindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!